Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Zafgen shares drop more than 40% as drug focus shifted
Zafgen shares drop more than 40% as drug focus shifted
Zafgen shares drop more than 40% as drug focus shifted
Submitted by
admin
on July 19, 2016 - 10:05pm
Source:
Marketwatch
News Tags:
Zafgen
beloranib
ZGN-1061
obesity
Headline:
Zafgen shares drop more than 40% as drug focus shifted
Do Not Allow Advertisers to Use My Personal information
